Association of malnutrition–inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients

A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial

(2011) Vincenzo Panichi et al.   BLOOD PURIFICATION

Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients

(2011) Mehmet KOC et al.   Hemodialysis International

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study

(2011) Heart Protection Study Collaborative Group   LANCET

Genomics of Cardiovascular Disease

(2011) Christopher J. O'Donnell et al.   NEW ENGLAND JOURNAL OF MEDICINE

The issue of studying the effect of interventions in renal replacement therapy -- to what extent may we be deceived by selection and competing risk?

(2010) K. J. Jager et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Linkage of Some Trace Elements, Peripheral Blood Lymphocytes, Inflammation, and Oxidative Stress in Patients Undergoing Either Hemodialysis or Peritoneal Dialysis

(2010) C.-H. Guoa et al.   PERITONEAL DIALYSIS INTERNATIONAL

Translating genomics into improved healthcare

(2010) A. D. Hingorani et al.   BMJ-British Medical Journal

Association of Quarterly Average Achieved Hematocrit With Mortality in Dialysis Patients: A Time-Dependent Comorbidity-Adjusted Model

(2009) Joseph M. Messana et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Evolving Statistical Methods to Facilitate Evaluation of the Causal Association Between Erythropoiesis-Stimulating Agent Dose and Mortality in Nonexperimental Research: Strengths and Limitations

(2009) Brian D. Bradbury et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients

(2009) Kamyar Kalantar-Zadeh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease

(2009) Paul Elliott   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Atorvastatin Increases Erythropoietin-Stimulating Agent Hyporesponsiveness in Maintenance Hemodialysis Patients: Role of Anti-Inflammation Effects

(2008) Chih-Kang Chiang et al.   AMERICAN JOURNAL OF NEPHROLOGY

Inflammation, T-Cell Phenotype, and Inflammatory Cytokines in Chronic Kidney Disease Patients Under Hemodialysis and its Relationship to Resistance to Recombinant Human Erythropoietin Therapy

(2008) Elísio Costa et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality

(2008) Juan M. López-Gómez et al.   KIDNEY INTERNATIONAL

Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes

(2008) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL

Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients

(2008) B. D. Bradbury et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease

(2007) D. Fouque et al.   KIDNEY INTERNATIONAL